The origins of Harklinikken
Lars Skjoth, Harklinikken founder and head of research and development, made a discovery in 1994 that makes it possible today for us to effectively treat hereditary hair loss in both women and men in a way that is customized to each client’s needs. Harklinikken Advisor Dr. Panos Vasiloudes joined Lars Skjoth in bringing Harklinikken to the American market because he saw a need for a more effective hair loss treatment for his patients. Dr. Vasiloudes is triple board certified, is licensed to practice medicine in four countries, and operates 18 dermatology clinics worldwide.
Harklinikken will grow beyond the clinic to help people in far-flung cities, but will remain true to its Danish roots. Lars Skjoth will continue to innovate and create new products to address Harklinikken clients’ hair and beauty concerns.
Meet our founder
Our leadership
LARS SKJOTH
Harklinikken Founder & Head Scientist
Lars Skjoth has worked to perfect his discovery of an effective treatment for thinning hair for more than two decades with clients on three continents. After many years of research and seeing thousands of clients experiencing thinning hair, he uncovered the precise combination of elements including some found in nature, that produce Harklinikken’s unparalleled results. Harklinikken is the only treatment for thinning hair that is customized for each client – a critical factor in the program’s success. A scientist of human nutrition and biochemistry, his invention of Harklinikken’s proprietary Extract has revolutionized the treatment of hair loss.
DR. PANOS VASILOUDES
Harklinikken Advisor
Panos Vasiloudes, MD, PhD, FAAD, FAAP, FASMS, is the President and CEO of Academic Alliance in Dermatology and Olympian Clinical Research. The West Central Florida practice consists of 19 dermatology clinics and a dermatopathology laboratory, with over 30 providers serving thousands of patients since 1988.
Dr. Vasiloudes was and is the primary investigator in over 100 clinical studies conducted within AAD and OCR over the last 30 years. AAD & OCR conduct phase II & III clinical trials in both adult and pediatric patients, in hopes of expediting the approval of new treatment options. A native of Cyprus, Dr. Vasiloudes holds a dual board certification in dermatology and pediatrics, as well as a PhD in the area of cell and molecular biology.
Since 2009, Dr. Vasiloudes has served as a global scientific advisor to Harklinikken. In this role, Dr Vasiloudes has seen thousands of patients treated effectively and safely by Harklinikken worldwide. Dr Vasiloudes has presented results around the world, including at the University of Florida, University of South Florida, University of Miami, All Childrens Hospital-John Hopkins Suncoast Conference, and venues in Freiburg and Marburg Germany, Cyprus, Dubai, and Iceland; culminating to his recent presentation in June 2019 at the World Congress in Dermatology, in Milano, Italy.
Dr Vasiloudes scientific interests include the early detection of melanoma, the role of nutrition in preventing skin cancer, nail health, and hair growth.
Complete our online assessment
100,000 clients on 3 continents have gotten their hair back.
